相关实验视频
Updated: May 20, 2025

08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
5.3K
海洋衍生的替代醇通过调节T细胞激活和迁移来抑制炎症
Chenfeng Liu1, Fudie Gu2, Zhengbiao Zou3
1Department of Cell Biology, School of Life Science, Anhui Medical University, Hefei 230031, China.
Marine drugs
|March 26, 2025
概括
海洋化合物Alternariol (AOH) 通过抑制T细胞增殖和细胞因子释放,有效地减少T细胞驱动的炎症. 这种海洋代谢物为炎症性疾病提供了有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 海洋天然产品 海洋天然产品
背景情况:
- T细胞是炎症过程的关键驱动力.
- 识别能调节T细胞功能的天然化合物对于控制炎症至关重要.
研究的目的:
- 为了研究海洋衍生化合物Alternariol (AOH) 的抗炎作用.
- 阐明AOH影响T细胞功能和炎症反应的机制.
主要方法:
- 使用一种由卵蛋白 (OVA) 诱导的OT-II CD4+ T细胞激活模型.
- 评估了T细胞增殖,细胞因子分泌,细胞亡和激活标记物的表达.
- 使用OVA诱导的肺损伤的小鼠模型进行了体内实验.
主要成果:
- AOH显著抑制了T细胞增殖和细胞因子分泌.
- AOH抑制了关键的T细胞激活标志物和转录因子,减少了Th1细胞因子的产生.
- 在体内,AOH通过减少免疫细胞透和抑制OVA特异性T细胞迁移来减轻肺损伤.
结论:
- 替代醇 (AOH) 通过调节T细胞的增殖,功能和迁移,显示出强大的抗炎作用.
- AOH为T细胞介导的炎症性疾病提供了一个有前途的治疗候选者.
相关概念视频
T Cell Types and Functions
724
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
724
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K

